Sclerostin as a biomarker of physical exercise in osteoporosis: A narrative review
Osteoporosis, a disease of low bone mass, is characterized by reduced bone mineral density (BMD) through abnormalities in the microarchitecture of bone tissue. It affects both the social and economic areas, therefore it has been considered a lifestyle disease for many years. Bone tissue is a dynamic...
Main Authors: | Anna Oniszczuk, Agnieszka Kaczmarek, Mateusz Kaczmarek, Maria Ciałowicz, Ersan Arslan, Ana Filipa Silva, Filipe Manuel Clemente, Eugenia Murawska-Ciałowicz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.954895/full |
Similar Items
-
Editorial: Exercise endocrinology: hormonal variations and relationships with acute and chronic exposure to exercise
by: Eugenia Murawska-Ciałowicz, et al.
Published: (2023-12-01) -
Anti-Sclerostin Antibodies in Osteoporosis and Other Bone Diseases
by: Stéphanie Fabre, et al.
Published: (2020-10-01) -
Osteoporosis Treatment with Anti-Sclerostin Antibodies—Mechanisms of Action and Clinical Application
by: Martina Rauner, et al.
Published: (2021-02-01) -
Multiple doses of SHR-1222, a sclerostin monoclonal antibody, in postmenopausal women with osteoporosis: A randomized, double-blind, placebo-controlled, dose-escalation phase 1 trial
by: Zhijie Dai, et al.
Published: (2023-04-01) -
The roles of sclerostin and irisin on bone and muscle of orchiectomized rats
by: Bing-na Zhou, et al.
Published: (2022-12-01)